Position in BBIO
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$639,261
New position
Shares Held
8,583
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#264
of 469 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Perpetual Ltd holds $110,919,281 across 11 Biotechnology names. BBIO ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,109,657 | $29,095,206 | |
| 2 | ARGX |
Argenx SE
|
28,246 | $26,205,790 | |
| 3 | GMAB |
Genmab A/S
|
919,048 | $25,246,248 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
104,264 | $25,124,495 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,407 | $1,500,860 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,897 | $942,296 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,722 | $819,403 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
This page
|
8,583 | $639,261 |
All Filings in BBIO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $639,261 | 8,583 | Shares | Defined | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||